Product Information

PHENTERMINE 8 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.6160 per EA under NDC 62135095990. Its NADAC has been published 35 times since Dec 24, 2025.

FDA first approved this application before 1982.

The High Outlier badge above means this manufacturer's average price in the Phentermine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PHENTERMINE 8 MG TABLET

Phentermine Hydrochloride
$0.6160per EA
High Outlier
DEA Schedule CIV

Strength

8 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135095990

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PHENTERMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA083923

FDA Approved

Before 1982

On Market Since

7/1/1976

Pharmacological Classes

Appetite Suppression
Increased Sympathetic Activity
Sympathomimetic Amine Anorectic

Price Statistics

The NADAC for PHENTERMINE 8 MG TABLET has been published 35 times since Dec 24, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.6160 per EA
All-time high$0.6160 (Aug 19, 2026)
All-time low$0.6144 (Dec 24, 2025)
52-week high$0.6160
52-week low$0.6144
Median price$0.6147
Average price$0.6148
Largest weekly change+0.1% (Jun 17, 2026)
Weeks tracked35
Tracking sinceDec 24, 2025

Price History

1W

+0.1%

1M

+0.1%

3M

+0.2%

6M

+0.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

+0.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of PHENTERMINE 8 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 8 MG TABLET, manufactured by Chartwell RX LLC, is $0.6160 per EA (NDC 62135095990), effective Aug 19, 2026.

How has the price of PHENTERMINE 8 MG TABLET changed over time?

Over the history we have for it, the NADAC for PHENTERMINE 8 MG TABLET has held within roughly two percent of its current level. It has been tracked across 35 weekly CMS publications since Dec 24, 2025.

What are the highest and lowest recorded NADAC prices for PHENTERMINE 8 MG TABLET?

Since Dec 24, 2025, the NADAC for PHENTERMINE 8 MG TABLET has ranged from a low of $0.6144 (Dec 24, 2025) to a high of $0.6160 (Aug 19, 2026), with a median of $0.6147 per EA.

Are there cheaper alternatives to PHENTERMINE 8 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PHENTERMINE 8 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PHENTERMINE 8 MG TABLET?

PHENTERMINE 8 MG TABLET (NDC 62135095990) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.